Location：
Home >
IPhEB Russia

IPhEB Russia

2026-02-06 13:49
48
Schedule: April 07- April 09, 2026
Location: Saint   Petersburg, Russia


About the Event
The leading exhibition dedicated to pharmaceutical packaging and drug delivery innovations,
bringing together industry experts, manufacturers, and innovators to showcase
cutting-edge technologies, sustainable solutions, and regulatory trends—shaping
the future of safe, patient-centric pharmaceutical packaging through

collaboration and knowledge exchange.


Utide Attendees   

展会参会3.png


ExhibitionSaint Petersburg, Russia
Prev CPHI Americas 2026
Next Utide Honored with National Peptide Industry Award for Scalable Production

Phase 3 Shock: Novo Nordisk’s CagriSema Loses to Eli Lilly’s Tirzepatide

2026-02-28
I. Market Insight: The New Standard of EfficacyOn February 23, 2026, Novo Nordisk released the REDEFINE 4 Phase 3 results—a head-to-head trial to challenge Eli Lilly’s GLP-1 market dominance. Data ...
News

Pfizer-Xianweida Collaboration Ignites GLP-1 API Boom: Guizhou Utide’s Customer Cases Reveal Its Core Strength

2026-02-28
       Recently, a major collaboration between Pfizer and Xianweida has become a hot topic in the global pharmaceutical industry — the two parties have joined hands to promote the commercializatio...
News

The Hidden War Behind the Pharmaceutical King's Succession: How a $36.5 Billion Order Tests the Global Supply Chain

2026-02-28
Ⅰ. A historic shiftIn 2025, the global pharmaceutical industrysaw a historic shift: Eli Lilly’s tirzepatide narrowlydethroned Novo Nordisk’s semaglutide as the new"King of Pharmaceuticals" with $36...
News

Eli Lilly’s GLP-1 Therapy Breakthrough:Global Peptide API Demand Surges, Highlighting UTIDE’s Guizhou Manufacturing& HK Commercial Capabilities

2026-02-28
1. Hot Spot Cut-In: Eli Lilly’s Trial Boosts GLP-1 Peptide API DemandOn January 8, 2026, Eli Lilly and Company announced positive top-line results from its Phase IIIb TOGETHER-PsA study, evaluating...
News

Starbucks Menu Overhaul: Viral High-Protein, Small-Portion Options Reveal Hidden Shifts in GLP-1 Supply Chain

2026-02-28
Seattle, USA — A pivotal shift from café menus to core manufacturing is underway, as global coffee giant Starbucks takes the lead in adapting to GLP-1-driven dietary changes by launching and expan...
News